Search Results for: cannabinoid

Sproutly Canada CEO Keith Dolo On Water-based Cannabinoid Technologies

The benefit of water-soluble cannabinoids is the quickened onset and offset times of cannabinoid ingestion while providing a higher level of control pertaining to dosage and duration.

CANADA:   Sproutly Canada Inc (CNSX:SPR) CEO Keith Dolo outlines how Sproutly’s development of water-based cannabinoid technologies, allowing the body to absorb THC and CBD compounds through water-solubility, rather than traditional oil based absorption. The benefit of water-soluble cannabinoids is the quickened onset and offset times of cannabinoid ingestion while providing a higher level of control Read the full article…

Study: Cannabinoid Therapy Improves Dystonia In HD Patients

"Treatment with cannabinoids in all cases lead to an improvement of motor symptoms, mainly driven by improvement of dystonia," authors concluded. Patients generally reported "no relevant side effects."

GERMANY: Cannabinoid treatment is associated with improvements in dystonia in patients with early-onset Huntington’s disease, according to observational data published online ahead of print in the Journal of Huntington’s Disease. A team of investigators from Germany and Austria assessed the treatment of various synthetic or organic cannabinoid preparations – including Sativex, dronabinol, and nabilone - in seven HD patients who had been Read the full article…

Review: Adjunctive Use Of Cannabinoids Efficacious In Patients With Treatment-Resistant Epilepsy

there was qualitative evidence that cannabinoids reduced seizure frequency in some patients, improved other aspects of the patients' quality of life and were generally well tolerated with mild-to-moderate AEs (adverse events)

AUSTRALIA: The adjunctive use of cannabinoids, particularly CBD (cannabidiol), typically reduces seizure frequency and improves the quality of life in patients with intractable forms of epilepsy, according to a review of clinical data published in the Journal ofNeurology, Neurosurgery & Psychiatry. Australian researchers reviewed data from six randomized, placebo-controlled studies, involving 555 patients, and from another 30 observational trials, Read the full article…

Skipta And The Fresh Toast Bring Cannabinoid Medicine Information To Healthcare Professionals

Skipta and The Fresh Toast

PENNSYLVANIA & WASHINGTON: Skipta, a leading social network of specialized online medical communities for verified healthcare professionals, including Oncology Nation, Psychiatrist Connect and Doctor Unite, announced today its partnership with new media company, The Fresh Toast, to provide trusted, reliable information on cannabinoid medicine. In a first for the cannabis industry, this partnership will provide guidelines and research information Read the full article…

Veterinary Cannabinoid Therapeutics Takes Center Stage At Cannabis in Veterinary Medicine Symposium

Do people really want a medical marijuana program for their pets?

A panel of seven Colorado doctors discuss using cannabis with animals COLORADO: Roughly 3-5% of all dogs have genetic epilepsy, and 14 million dogs have some form of arthritis. CBD oil is helping millions of people around the world, and as a result the veterinary medical market is becoming more aware of the relief CBD can Read the full article…

Nanoparticle Drones To Target Lung Cancer with Radiosensitizers And Cannabinoids

nanotechnology

Wilfred Ngwa1,2*, Rajiv Kumar1,3, Michele Moreau1,2, Raymond Dabney4 and Allen Herman4 1Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States 2University of Massachusetts Lowell, Lowell, MA, United States 3Northeastern University, Boston, MA, United States 4Cannabis Science Inc., Irvine, CA, United States   CALIFORNIA: Nanotechnology has opened up a new, previously unimaginable Read the full article…

International Collaborative Study Reveals The Neuroprotective Properties of Phytocannabinoid Δ9-THCA

A recent Δ9-THCA (Δ9-tetrahydrocannabinol acid) study, initiated by three leading companies active in the field of medicinal cannabis research, has demonstrated its ability as a promising treatment modality for Huntington's disease (HD) and other metabolic, neurodegenerative and neuroinflammatory diseases.

SPAIN:  Advanced medical research conducted at Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC) as a collaborative effort between Phytoplant Research SL, VivaCell Biotechnology España SL, and Emerald Health Pharmaceuticals has unveiled the potent neuroprotective ability of Δ9-THCA, a phytocannabinoid produced in Cannabis sativa L. The research paper was accepted and published in the British Journal of Pharmacology. Read the full article…

Case Reports: Cannabinoids Improve Speech In Patients With Tourette Syndrome

Cannabinoids Improve Speech In Patients With Tourette Syndrome

GERMANY: The daily administration of cannabinoids is associated with improved speech fluency in patients with Tourette Syndrome (TS), according to a pair of case reports published in The International Journal of Molecular Sciences. A pair of researchers from the Hannover Medical School in Germany assessed the impact of daily cannabinoid treatment in two TS patients with treatment-resistant vocal Read the full article…

Intec Pharma Reports Clinical Results From Phase I Trial of Accordion Pill For Cannabinoid Therapies

Intec Pharma Reports Clinical Results From Phase I Trial of Accordion Pill for Cannabinoid Therapies

ISRAEL: Intec Pharma, a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, announced the results from a Phase I clinical trial of AP-CBD/THC, its Accordion Pill platform with cannabidiol (CBD) and tetrahydrocannabinol (THC), the two primary cannabinoids contained in Cannabis sativa. “We’re excited about these encouraging results from our Read the full article…

OWC Pharmaceutical To Begin Testing On Cannabinoid-Infused Psoriasis Cream

Cannabis-infused Psoriasis cream

ISRAEL: OWC Pharmaceutical Research Corp., an Israeli-based developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, announced it has received Institutional Review Board (IRB) approval to conduct safety testing on its proprietary topical crème compound for the treatment of psoriasis and related skin conditions. The approval follows the Company’s February 1, 2017 8K filing Read the full article…